Biochemical and biophysical characterization of ruthenation of BRCA1 RING protein by RAPTA complexes and its E3 ubiquitin ligase activity

Biochemical and Biophysical Research Communications
Pornvichai TembootAdisorn Ratanaphan

Abstract

RAPTA compounds, ([Ru(η6-arene)(PTA)Cl2], PTA = 1,3,5-triaza-7-phosphaadamantane), have been reported to overcome drug resistance in cisplatin resistant cells. However, the exact mechanism of these complexes is still largely unexplored. In this study, the interaction of some RAPTA compounds with the N-terminal fragment of the BRCA1 RING domain protein was investigated. The binding of the RAPTA compounds to the BRCA1 protein resulted in a release of Zn2+ ions in a dose and time dependent manner, as well as thermal alteration of ruthenated-BRCA1 proteins. Electron Transfer Dissociation (ETD) fragmentation mass spectrometry revealed the preferential binding sites of the RAPTA complexes on the BRCA1 zinc finger RING domain at a similar short peptide stretch, Cys24Lys25Phe26Cys27Met28Leu29 and Lys35 (residues 44-49 and 55 on full length BRCA1). Changes in the conformation and binding constants of ruthenium-BRCA1 adducts were established, resulting in inactivation of the RING heterodimer BRCA1/BARD1-mediated E3 ubiquitin ligase function. These findings could provide mechanistic insight into the mode of action of RAPTA complexes for on tested BRCA1 model protein.

References

Feb 6, 1996·Proceedings of the National Academy of Sciences of the United States of America·P J TumminoD Hupe
Mar 30, 2001·The Journal of Biological Chemistry·R HashizumeT Ohta
Apr 26, 2001·Proceedings of the National Academy of Sciences of the United States of America·H RuffnerI M Verma
May 7, 2003·Proceedings of the National Academy of Sciences of the United States of America·Peter S BrzovicRachel Klevit
May 17, 2005·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Viktor Brabec, Jana Kasparkova
Jun 10, 2005·Journal of Medicinal Chemistry·Claudine ScolaroPaul J Dyson
Apr 28, 2009·Angewandte Chemie·Wee Han AngPaul J Dyson
Sep 30, 2010·Breast Cancer Research and Treatment·Apichart AtipairinAdisorn Ratanaphan
Oct 23, 2010·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Apichart AtipairinAdisorn Ratanaphan
Jan 22, 2011·Metallomics : Integrated Biometal Science·Susana M QuintalNicholas P Farrell
Mar 14, 2013·Journal of Chemical Information and Modeling·Luc Patiny, Alain Borel
Mar 12, 2015·Scientific Reports·Andrea WeissPatrycja Nowak-Sliwinska
Jul 28, 2016·The Journal of Clinical Investigation·Yifan WangNeil Johnson

❮ Previous
Next ❯

Citations

Apr 25, 2019·Apoptosis : an International Journal on Programmed Cell Death·Tidarat NhukeawAdisorn Ratanaphan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.